Biliary Atresia Post Hepatoportoenterostomy clinical trials

Explore recruiting biliary atresia post hepatoportoenterostomy clinical trials.

Recruiting biliary atresia post hepatoportoenterostomy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Biliary Atresia Post Hepatoportoenterostomy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Placebo-controlled, Phase 2/3 Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Obeticholic Acid Compared to Placebo in Pediatric Subjects with Biliary Atresia, Post-hepatoportoenterostomy

Belgium, Germany, Netherlands, France, Italy, Spain +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Biliary Atresia Post Hepatoportoenterostomy trials by city

Biliary Atresia Post Hepatoportoenterostomy in Toronto Biliary Atresia Post Hepatoportoenterostomy in Vancouver Biliary Atresia Post Hepatoportoenterostomy in Montreal Biliary Atresia Post Hepatoportoenterostomy in Calgary Biliary Atresia Post Hepatoportoenterostomy in Edmonton Biliary Atresia Post Hepatoportoenterostomy in Ottawa Biliary Atresia Post Hepatoportoenterostomy in Winnipeg Biliary Atresia Post Hepatoportoenterostomy in Quebec City Biliary Atresia Post Hepatoportoenterostomy in Hamilton Biliary Atresia Post Hepatoportoenterostomy in Kitchener Biliary Atresia Post Hepatoportoenterostomy in London Biliary Atresia Post Hepatoportoenterostomy in Halifax Biliary Atresia Post Hepatoportoenterostomy in New York Biliary Atresia Post Hepatoportoenterostomy in Los Angeles Biliary Atresia Post Hepatoportoenterostomy in Chicago Biliary Atresia Post Hepatoportoenterostomy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease